SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-19-000013
Filing Date
2019-05-07
Accepted
2019-05-07 17:06:39
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q1x2019.htm 10-Q 831692
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 25360
3 EXHIBIT 31.1 exhibit311q12019.htm EX-31.1 9695
4 EXHIBIT 31.2 exhibit312q12019.htm EX-31.2 9658
5 EXHIBIT 32.1 exhibit321q12019.htm EX-32.1 10010
  Complete submission text file 0000827871-19-000013.txt   5106983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT egrx-20180930.xml EX-101.INS 970329
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20180930.xsd EX-101.SCH 37551
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20180930_cal.xml EX-101.CAL 97462
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20180930_def.xml EX-101.DEF 175263
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20180930_lab.xml EX-101.LAB 550672
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20180930_pre.xml EX-101.PRE 329960
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 19804075
SIC: 2834 Pharmaceutical Preparations